SEC Tracker
Get the app

Kyntra Bio KYNB

Kyntra Bio faces delisting threat

Form
8-K
Filed
Importance
Major
  1. Received delisting notice from Nasdaq on Sep 30, 2026
  2. Requested hearing to challenge delisting decision
  3. Previously non-compliant with Nasdaq listing rules since Apr 2, 2026
  4. Stock remains listed pending panel decision

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Kyntra Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  2. Imunon IMNN public float $21M, Jun 30, 2025
  3. Lunai Bioworks LNAI public float $21M, Dec 31, 2025
  4. Dare Bioscience DARE public float $21M, Jun 30, 2025
  5. Aptose Biosciences APTOF public float $22M, Jun 28, 2025